This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Apr;227(2):226-7.

doi: 10.1016/j.atherosclerosis.2012.11.018. Epub 2012 Nov 23.

The enigma of adiponectin

Mogens Fenger¹

Affiliations

PMID: 23337797
DOI: 10.1016/j.atherosclerosis.2012.11.018

Comment

The enigma of adiponectin

Mogens Fenger. Atherosclerosis. 2013 Apr.

. 2013 Apr;227(2):226-7.

doi: 10.1016/j.atherosclerosis.2012.11.018. Epub 2012 Nov 23.

Author

Mogens Fenger¹

Affiliation

¹ University Hospital of Copenhagen, Medical Biochemistry, Genetics, and Molecular Biology, Kettegaard Alle 30, 2650 Hvidovre, Denmark. mfenger@anarki.dk

PMID: 23337797
DOI: 10.1016/j.atherosclerosis.2012.11.018

No abstract available

PubMed Disclaimer

Comment on

Effects of pravastatin on serum adiponectin levels in female patients with type 2 diabetes mellitus.
Kim JH, Lee MR, Shin JA, Lee SS, Lee JM, You SJ, Yoon KH, Chang SA. Kim JH, et al. Atherosclerosis. 2013 Apr;227(2):355-9. doi: 10.1016/j.atherosclerosis.2013.01.045. Epub 2013 Feb 11. Atherosclerosis. 2013. PMID: 23466100 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal